The COVID-19 pandemic brought tremendous change to the molecular diagnostics (MDx) industry, delivering opportunities ...
Read more
Can COVID-19 testing be made more sustainable during prolonged uncertainty?
In September 2021, Delta persists as the most prevalent variant worldwide due to its high infectivity, causing surges in COVID-19 cases to the point where some areas are reopening mass testing centres. As long as COVID-19 continues to defy expectations and predictions, testing will play a key role in managing the virus - whether it’s for re-introducing activities that provide a sense of normalcy or for the surveillance of emerging variants. With some local governments incorporating mandatory testing requirements into their re-opening strategies, there is growing concern about the availability and supply-chain resilience in order to access testing reagents and supplies to support another spike in demand.
Read moreThe BiosearchTech Blog
As SARS-CoV-2 variants continue to threaten public health, officials are looking beyond clinical tests to track ...
Read more
Topics: Coronavirus, SARS-CoV-2, Variants
Emerging SARS-CoV-2 variants of concern and variants of interest are defined by agencies such as the World Health ...
Read more
Topics: Coronavirus, SARS-CoV-2, Variants
As the global population gains greater access to vaccines for COVID-19, scientists and health officials continue to ...
Read more
Topics: Molecular Diagnostics, Genomics, Coronavirus, MDx, SARS-CoV-2, Variants
Researchers have identified several variants of SARS-CoV-2 since they sequenced the original viral strain responsible ...
Read more
Topics: Molecular Diagnostics, Coronavirus, MDx, SARS-CoV-2, Variants
As we start to close in on a full year of the COVID-19 pandemic, molecular diagnostics labs are still facing supply ...
Read more
Topics: Molecular Diagnostics, Genomics, Coronavirus
Following up with the panelists from our recent COVID-19 webinar, Part 3 of 3 In the previous two blog posts in this ...
Read more
Topics: Molecular Diagnostics, Genomics, Coronavirus
Following up with the panelists from our recent COVID-19 webinar, Part 2 of 3 In the face of a rapidly evolving ...
Read more
Topics: Molecular Diagnostics, Genomics, Coronavirus
Following up with the panelists from our recent COVID-19 webinar, Part 1 of 3 The COVID-19 pandemic has presented ...
Read more
Topics: Molecular Diagnostics, Genomics, Coronavirus
As countries worldwide begin to ease lockdown restrictions during the pandemic and prepare to return to “normal” ...
Read more
Topics: Molecular Diagnostics, Genomics, qPCR, Coronavirus
It may seem strange that a company known for transforming the global seed breeding industry is uniquely positioned to ...
Read more
Topics: Molecular Diagnostics, Genomics, qPCR, Coronavirus
We’re not rejecting you, just your oligo PCR is arguably one of the most enabling technologies of modern molecular ...
Read more
Topics: Molecular Diagnostics, Genomics, Coronavirus, Oligo synthesis
On March 25, 2020, the US Food and Drug Administration (FDA) held the first of a series of virtual town halls they will ...
Read more
Topics: Molecular Diagnostics, Coronavirus
In the nearly three months since the first confirmed case of COVID-19, the outbreak has become a global crisis, with ...
Read more
Topics: Molecular Diagnostics, Custom Oligos, Genomics, Coronavirus
*Since the original publication of this blog, LGC, Biosearch Technologies is now the only acceptable commercial ...
Read more
Topics: Molecular Diagnostics, Genomics, Coronavirus
Coronavirus, or COVID-19, is an infectious virus that is spreading rapidly around the world and the World Health ...
Read more
Topics: Molecular Diagnostics, Genomics, Coronavirus